Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 25 Uterine Cervical Neoplasms 6 Melanoma 5 Endometrial Neoplasms 5 Mouth Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Vulvar Neoplasms 2 Uterine Neoplasms 2 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Lymphatic Metastasis 2 Head and Neck Neoplasms 2 Recurrence 1 Recurent Vulvar Carcinoma 1 Penile Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Node-positive Breast Cancer 1 Neoplasm Micrometastasis 1 Neoplasm Metastasis 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cervical Adenocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal 1 Carcinoma 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1

Interventions

Radiotherapy 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Cyclophosphamide 7 Busulfan 7 Whole-Body Irradiation 6 Melphalan 6 Radiofrequency Ablation 5 Mycophenolic Acid 5 Filgrastim 5 Antilymphocyte Serum 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Methotrexate 4 Etoposide 4 Drug Therapy 4 Cisplatin 4 fludarabine 3 Radiosurgery 3 Injections 3 Hepatectomy 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 lenvatinib 2 Vinblastine 2 Videotape Recording 2 Thiotepa 2 Standard of Care 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Sentinel Lymph Node Biopsy × Clear all

NCT03719547 2025-07-01

RACC

Karolinska Institutet

Phase NA Recruiting

Uterine Cervical Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡